1. Home
  2. KOD

KOD

Kodiak Sciences Inc

Logo Kodiak Sciences Inc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Founded: 2009 Country:
United States
United States
Employees: N/A City: PALO ALTO
Market Cap: 234.2M IPO Year: 2018
Target Price: $3.25 AVG Volume (30 days): 935.0K
Analyst Decision: Sell Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.97 EPS Growth: N/A
52 Week Low/High: $1.37 - $9.80 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: